ArticleSensors (Basel, Switzerland)2026
Application of Deep Multi-Scale Representation Learning Based on Eye-Tracking and Facial Expression Data in Cognitive Decline Assessment.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Facial phenotypes in Alzheimer's disease: from neurobiology to artificial intelligence.Alzheimer's research & therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Digital biomarkers derived from eye-tracking and facial expression hold significant potential for the non-invasive screening of cognitive decline (CD). However, existing approaches predominantly rely on single-task or feature engineering-based unimodal methods, which struggle to capture complex temporal behavioral patterns. While deep learning (DL) excels at extracting hierarchical features and intricate temporal dynamics from behavioral sequences, its application in this specific multimodal sensing domain remains exploratory. Addressing this gap, this study designed an assessment system integrating five multi-dimensional cognitive paradigms and collected eye-tracking and facial expression data from 20 healthy controls (HC) and 20 individuals with CD. For these multimodal sequences, we propose a deep neural network capable of multi-scale representation learning. By utilizing subspace exploration and multi-scale convolutions, this architecture extracts deep representations directly from data and incorporates a decision fusion mechanism to enhance diagnostic robustness. Experimental results demonstrate that our method achieves a 90% classification accuracy, outperforming machine learning models. Furthermore, statistical analyses conducted in this study validated several features associated with CD and also explored some novel potential behavioral patterns. This study confirms the feasibility of a DL framework based on eye-tracking and facial expression signals for identifying CD, providing a reference for developing objective and efficient digital screening tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.